JD
Insider
Joaquin Duato
CEO and Chairman of the BoardJoaquin Duato (CEO and Chairman of the Board) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Johnson & Johnson (JNJ). The largest single filing was $32.2M of JNJ (123,291 sh across 2 lots, as filed), executed Aug 13.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$66.8M
shares × price, as filed
Last traded
Aug 13
Filed Aug 14
Median ADV $2.2B across their filed names
Open performance→Volume by month
Buys $0
Sells $89.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
JNJ
Johnson & Johnson
JNJ · 0 buys · 4 sells
4 filings
Recent filings
JNJSALE
Johnson & Johnson
View filing →
$32.2M123,291 sh across 2 lots
Exec Aug 13
Filed Aug 14 · 4:35 PM ET JNJSALE Johnson & Johnson View filing → $12.5M
48,480 sh across 2 lots
Exec Aug 5
Filed Aug 7 · 5:50 PM ET JNJSALE Johnson & Johnson View filing → $22.1M
100,000 sh across 2 lots
Exec Jan 26
Filed Jan 28 · 5:30 PM ET JNJSALE Johnson & Johnson View filing → $22.5M
125,824 sh × $179.21
Exec Aug 22 2025
Filed Aug 25 2025 · 5:30 PM ET